Orca Bio vs Neuralink
Side-by-side comparison of AI visibility scores, market position, and capabilities
Orca Bio is developing high-purity precision cell therapies using proprietary cell sorting technology to improve the safety and outcomes of bone marrow transplantation; raised $270M+; lead programs in AML, MDS, and other blood cancers;
About
Orca Bio is a Menlo Park, California-based biotechnology company founded in 2016 that is developing next-generation cell therapies for blood cancers and autoimmune diseases through a proprietary high-precision cell sorting and manufacturing platform. The company's core technology enables the production of precisely defined cell therapy products — specifically, highly purified stem cell grafts and engineered immune cell compositions for allogeneic (donor-to-patient) bone marrow transplantation. Unlike conventional bone marrow transplants, which transfer a heterogeneous mixture of cells that can attack the patient's body (graft-versus-host disease, or GVHD), Orca Bio's manufactured grafts are composed of precisely selected cell populations that retain the anti-cancer effect while dramatically reducing the cells responsible for GVHD.
Pioneer of implantable BCIs with 12+ active human patients as of Sep 2025; raised $650M Series E in Apr 2026 led by ARK Invest and Sequoia at a ~$14.9B valuation; mass production underway.
About
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with paralysis to control digital devices directly with their thoughts. The company's first commercial product, the N1 implant, is a coin-sized device containing 1,024 electrodes that is surgically placed in the motor cortex. As of September 2025, twelve patients worldwide had received the N1 implant and were actively using it to control computers, smartphones, and robotic arms with neural signals alone.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.